RT @jessrzanotti
@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter
46yo 👩🏻 asymptomatic
no comorb
🌀Screening abd US: liver nodules + pancreatic mass (body/tail)
🔬Liver bx + NET G2 Ki67 12%
🩻PET-Ga + uptake in pancreas & liver (SUVs>20)
💉1L: Lanreotide SC - DP liver after 1y (⬆️volume)
🤨What 2L tx?

RT @jessrzanotti
@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter
46yo 👩🏻 asymptomatic
no comorb
🌀Screening abd US: liver nodules + pancreatic mass (body/tail)
🔬Liver bx + NET G2 Ki67 12%
🩻PET-Ga + uptake in pancreas & liver (SUVs>20)
💉1L: Lanreotide SC - DP liver after 1y (⬆️volume)
🤨What 2L tx?

RT @jessrzanotti
@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter
46yo 👩🏻 asymptomatic
no comorb
🌀Screening abd US: liver nodules + pancreatic mass (body/tail)
🔬Liver bx + NET G2 Ki67 12%
🩻PET-Ga + uptake in pancreas & liver (SUVs>20)
💉1L: Lanreotide SC - DP liver after 1y (⬆️volume)
🤨What 2L tx?

RT @jessrzanotti
@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter
46yo 👩🏻 asymptomatic
no comorb
🌀Screening abd US: liver nodules + pancreatic mass (body/tail)
🔬Liver bx + NET G2 Ki67 12%
🩻PET-Ga + uptake in pancreas & liver (SUVs>20)
💉1L: Lanreotide SC - DP liver after 1y (⬆️volume)
🤨What 2L tx?

RT @jessrzanotti
@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter
46yo 👩🏻 asymptomatic
no comorb
🌀Screening abd US: liver nodules + pancreatic mass (body/tail)
🔬Liver bx + NET G2 Ki67 12%
🩻PET-Ga + uptake in pancreas & liver (SUVs>20)
💉1L: Lanreotide SC - DP liver after 1y (⬆️volume)
🤨What 2L tx?

It's here! #TumorBoardTuesday featuring latest management strategies for NET, including hypermutated NET. Can't wait to learn 📚!
---
RT @jessrzanotti
@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter
46yo 👩🏻 asymptomatic
no comorb
🌀Screening abd US: liver nodules + pancreatic mass (body/tail)
🔬Liver bx + NET G2 Ki67 12%
🩻PET-Ga + uptake in pancreas & liver (SUVs>20)
💉1L: Lanreotide SC - DP liver after 1y (⬆️volume)
🤨What 2L …
https://twitter.com/jessrzanotti/status/1653549758072471553

📢 Join our 🇧🇷 Brazilian-led #TumorBoardTuesday!!

🥼@RachelRiechelm2 @jessrzanotti teach us treating hypermutation induced in NET #PancreaticCancer
👇🏽

📱Weigh in
🧾Bring receipts
🙋Ask Q’s
📊check polls
🔁RT
👩🏻‍⚕️tag peers
@MPishvaian @JohnEbbenMDPhD
#MedTwitter #WomenInOncology
---
RT @jessrzanotti
@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter
46yo 👩🏻 asymptomatic
no comorb
🌀Screening abd US: liver nodules + pancreatic mass …
https://twitter.com/jessrzanotti/status/1653549758072471553

RT @jessrzanotti
@TumorBoardTues 1/15 #TumorBoardTuesday #PanCan #OncTwitter
46yo 👩🏻 asymptomatic
no comorb
🌀Screening abd US: liver nodules + pancreatic mass (body/tail)
🔬Liver bx + NET G2 Ki67 12%
🩻PET-Ga + uptake in pancreas & liver (SUVs>20)
💉1L: Lanreotide SC - DP liver after 1y (⬆️volume)
🤨What 2L tx?

🦓1 hour until TONIGHT'S #TumorBoardTuesday!!

🇧🇷@RachelRiechelm2 @jessrzanotti take us through treatment of hypermutation induced by alkylating agent in #PanCan

🦓Finish dinner, grab a drink, and prepare your 🧠 with these #CME

👇🏽See you soon!

---
RT @TumorBoardTues
#TumorBoardTuesday #PreTest Q1⃣
Free #CME🔗http://integrityce.com/TBT2023

📣B4 @RachelRiechelm2 @jessrzanotti teach us hypermutation #NETCancer test your🧠

🤔Which 2L fo…
https://twitter.com/TumorBoardTues/status/1653449001700556816

🇧🇷 Be sure to join #TumorBoardTuesday 05/02 at 8pm! #PanCan #NETCancer

@PreetpaulS @JaydiDelRivero @TClancyMD @LMFendo @ShaalanBeg @HealingNET1 @laylaPLANETSCh1 @DrMohidKhan @ShalabyK @jgong15 @drjasonstarr @NVijayvergiaMD @jhatjhmi1 @GillSharlene @nanudasmd @DrSukeshiArora… https://twitter.com/i/web/status/1653106342792396800

RT @TumorBoardTues
Thank you 🙏🏼 for a wonderfully educational & useful #TumorBoardTuesday!!

Look for Case Wrap Up 🎀 Thursday 04/27/23

📅This Tuesday we’re joined from Brazil at 8pm ET/9pm 🇧🇷 by @RachelRiechelm2 @jessrzanotti to discuss hypermutation neuroendocrine tumor #PanCan

Thank you to the #MedTwitter #OncTwitter community - We couldn't have successful #TumorBoardTuesday without your support, encouragement, and engagement!
#LCSM #BCSM #GITwitter #PanCan #GU #HemOnc

RT @marijasullivan
@TumorBoardTues @JenniferLitton 1/18 #TumorBoardTuesday #BreastCancer #OncTwitter

32 yo 👩🏽
4 months post-partum
🚫comorbidities
FHx paternal uncle with #PanCan
🔬Bx: L breast mass - IDC, G3, ER 50%, PR 30%, HER2 0, Ki67 30%
Clinically node+; FNA confirms LN involvement
🚫 e/o metastatic dz

🤔Do all EXCEPT?

RT @marijasullivan
@TumorBoardTues @JenniferLitton 1/18 #TumorBoardTuesday #BreastCancer #OncTwitter

32 yo 👩🏽
4 months post-partum
🚫comorbidities
FHx paternal uncle with #PanCan
🔬Bx: L breast mass - IDC, G3, ER 50%, PR 30%, HER2 0, Ki67 30%
Clinically node+; FNA confirms LN involvement
🚫 e/o metastatic dz

🤔Do all EXCEPT?

RT @marijasullivan
@TumorBoardTues @JenniferLitton 1/18 #TumorBoardTuesday #BreastCancer #OncTwitter

32 yo 👩🏽
4 months post-partum
🚫comorbidities
FHx paternal uncle with #PanCan
🔬Bx: L breast mass - IDC, G3, ER 50%, PR 30%, HER2 0, Ki67 30%
Clinically node+; FNA confirms LN involvement
🚫 e/o metastatic dz

🤔Do all EXCEPT?

It's here! Time for #TumorBoardTuesday. This week, @marijasullivan & @JenniferLitton explore unique considerations for younger pts w BRCA2+ #breastcancer. @BRCAUmbrella @LivingBeyondBC @BreastCaupdates
---
RT @marijasullivan
@TumorBoardTues @JenniferLitton 1/18 #TumorBoardTuesday #BreastCancer #OncTwitter

32 yo 👩🏽
4 months post-partum
🚫comorbidities
FHx paternal uncle with #PanCan
🔬Bx: L breast mass - IDC, G3, ER 50%, PR 30%, HER2 …
https://twitter.com/marijasullivan/status/1648476524369313797

RT @marijasullivan
@TumorBoardTues @JenniferLitton 1/18 #TumorBoardTuesday #BreastCancer #OncTwitter

32 yo 👩🏽
4 months post-partum
🚫comorbidities
FHx paternal uncle with #PanCan
🔬Bx: L breast mass - IDC, G3, ER 50%, PR 30%, HER2 0, Ki67 30%
Clinically node+; FNA confirms LN involvement
🚫 e/o metastatic dz

🤔Do all EXCEPT?

RT @marijasullivan
@TumorBoardTues @JenniferLitton 1/18 #TumorBoardTuesday #BreastCancer #OncTwitter

32 yo 👩🏽
4 months post-partum
🚫comorbidities
FHx paternal uncle with #PanCan
🔬Bx: L breast mass - IDC, G3, ER 50%, PR 30%, HER2 0, Ki67 30%
Clinically node+; FNA confirms LN involvement
🚫 e/o metastatic dz

🤔Do all EXCEPT?

RT @KrishanJethwa@twitter.com

Thanks for the invite! It was great learning from you all!

🔑 We need to work together to identify/incorporate non-anatomical means of prediction/prognostication to guide “optimal” neoadjuvant tx for PDAC!

Looking forward to continued collaboration to help patients with #Pancan https://twitter.com/freddyeescorcia/status/1615750526410559490

🐦🔗: https://twitter.com/KrishanJethwa/status/1615791050890612739

Today would have been my youngest sister's birthday. She passed away due to pancreatic cancer 2+ years ago.

There are no screening tests for pancan. There are no lumps, bumps, or odd growths.

It is typically discovered because you have some odd symptom. When it is found it is usually too late. She was diagnosed in May and died the following October.

The 5 year survival rate is *10* percent.

#pancan #cancer #cancerresearch